表紙:癌分子診断の世界市場:COVID-19による成長および変化の見通し (~2030年)
市場調査レポート
商品コード
1028945

癌分子診断の世界市場:COVID-19による成長および変化の見通し (~2030年)

Oncology Molecular Diagnostics Global Market Report 2021: COVID-19 Growth And Change To 2030

出版日: 受注後作成 | 発行: The Business Research Company | ページ情報: 英文 175 Pages | 納期: 2~10営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=115.72円
癌分子診断の世界市場:COVID-19による成長および変化の見通し (~2030年)
出版日: 受注後作成
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2~10営業日
  • 全表示
  • 概要
  • 目次
概要

当レポートでは、世界の癌分子診断の市場を調査し、市場の定義と概要、新型コロナウイルス感染症 (COVID-19) およびその他の市場影響因子の分析、市場規模の推移・予測、製品・技術・エンドユーザー・地域/主要国など各種区分別の内訳、競合環境、主要企業のプロファイル、将来の展望などをまとめています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向・市場戦略

第4章 COVID-19の影響

第5章 市場規模・成長予測

  • 市場規模の推移・予測
  • 市場成長推進因子
  • 市場成長抑制因子

第6章 市場分析・予測:各種区分別

  • 製品別
    • 機器
    • 試薬
    • その他
  • 技術別
    • ポリメラーゼ連鎖反応(PCR)
    • インサイチュハイブリダイゼーション(ISH)
    • 等温核酸増幅技術(INNAT)
    • チップ・マイクロアレイ
    • シーケンシング
    • 質量分析
    • 転写媒介増幅(TMA)
    • その他
  • エンドユーザー別
    • 病院
    • 診断センター
    • 学術・研究機関
    • その他

第7章 市場分析・予測:地域・国別

第8章 アジア太平洋市場の分析・予測

  • 市場概要
  • 地域情報・COVID-19の影響・市場情報・背景情報・政府イニシアチブ・法規制・機関&協会・租税・投資・主要企業
  • 市場分析・予測:製品別
  • 市場分析・予測:技術別

第9章 中国市場の分析・予測

第10章 インド市場の分析・予測

第11章 日本市場の分析・予測

第12章 オーストラリア市場の分析・予測

第13章 インドネシア市場の分析・予測

第14章 韓国市場の分析・予測

第15章 西欧市場の分析・予測

第16章 英国市場の分析・予測

第17章 ドイツ市場の分析・予測

第18章 フランス市場の分析・予測

第19章 東欧市場の分析・予測

第20章 ロシア市場の分析・予測

第21章 北米市場の分析・予測

第22章 米国市場の分析・予測

第23章 南米市場の分析・予測

第24章 ブラジル市場の分析・予測

第25章 中東市場の分析・予測

第26章 アフリカ市場の分析・予測

第27章 競合情勢・企業プロファイル

  • 競合情勢
  • 企業プロファイル
    • Abbott Diagnostics
    • Becton Dickinson
    • Cepheid
    • Danaher Corporation
    • Beckman Coulter

第28章 主なM&A

第29章 将来の展望・潜在性の分析

第30章 付録

目次
Product Code: h970

Oncology Molecular Diagnostics Global Market Report 2021: COVID-19 Growth And Change to 2030 from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global oncology molecular diagnostics market.

This report focuses on oncology molecular diagnostics market which is experiencing strong growth. The report gives a guide to the oncology molecular diagnostics market which will be shaping and changing our lives over the next ten years and beyond, including the markets response to the challenge of the global pandemic.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Where is the largest and fastest growing market for the oncology molecular diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Oncology Molecular Diagnostics market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider oncology molecular diagnostics market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the COVID-19 virus and forecasting its growth.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The oncology molecular diagnostics market section of the report gives context. It compares the oncology molecular diagnostics market with other segments of the oncology molecular diagnostics market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, oncology molecular diagnostics indicators comparison.

Scope

Markets Covered:

1) By Product: Instruments; Reagents; Others

2) By Technology: Polymerase Chain Reaction (PCR); In-situ Hybridization (ISH); Isothermic Nucleic Acid Amplification Technology (INNAT); Chips & Microarrays; Sequencing; Mass Spectroscopy; Transcription Mediated Amplification (TMA); Others

3) By End User: Hospitals; Diagnostic Centers; Academic & Research Institutes; Others

Companies Mentioned: Abbott Diagnostics; Becton Dickinson; Cepheid; Danaher Corporation; Beckman Coulter

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Executive Summary

2. Oncology Molecular Diagnostics Market Characteristics

3. Oncology Molecular Diagnostics Market Trends And Strategies

4. Impact Of COVID-19 On Oncology Molecular Diagnostics

5. Oncology Molecular Diagnostics Market Size And Growth

  • 5.1. Global Oncology Molecular Diagnostics Historic Market, 2015-2020, $ Billion
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints On The Market
  • 5.2. Global Oncology Molecular Diagnostics Forecast Market, 2020-2025F, 2030F, $ Billion
    • 5.2.1. Drivers Of The Market
    • 5.2.2. Restraints On the Market

6. Oncology Molecular Diagnostics Market Segmentation

  • 6.1. Global Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Instruments
  • Reagents
  • Others
  • 6.2. Global Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Polymerase Chain Reaction (PCR)
  • In-situ Hybridization (ISH)
  • Isothermic Nucleic Acid Amplification Technology (INNAT)
  • Chips & Microarrays
  • Sequencing
  • Mass Spectroscopy
  • Transcription Mediated Amplification (TMA)
  • Others
  • 6.3. Global Oncology Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Hospitals
  • Diagnostic Centers
  • Academic & Research Institutes
  • Others

7. Oncology Molecular Diagnostics Market Regional And Country Analysis

  • 7.1. Global Oncology Molecular Diagnostics Market, Split By Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 7.2. Global Oncology Molecular Diagnostics Market, Split By Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

8. Asia-Pacific Oncology Molecular Diagnostics Market

  • 8.1. Asia-Pacific Oncology Molecular Diagnostics Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 8.3. Asia-Pacific Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

9. China Oncology Molecular Diagnostics Market

  • 9.1. China Oncology Molecular Diagnostics Market Overview
  • 9.2. China Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion
  • 9.3. China Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion

10. India Oncology Molecular Diagnostics Market

  • 10.1. India Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 10.2. India Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

11. Japan Oncology Molecular Diagnostics Market

  • 11.1. Japan Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 11.2. Japan Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

12. Australia Oncology Molecular Diagnostics Market

  • 12.1. Australia Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 12.2. Australia Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

13. Indonesia Oncology Molecular Diagnostics Market

  • 13.1. Indonesia Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 13.2. Indonesia Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

14. South Korea Oncology Molecular Diagnostics Market

  • 14.1. South Korea Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 14.2. South Korea Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

15. Western Europe Oncology Molecular Diagnostics Market

  • 15.1. Western Europe Oncology Molecular Diagnostics Market Overview
  • 15.2. Western Europe Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 15.3. Western Europe Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

16. UK Oncology Molecular Diagnostics Market

  • 16.1. UK Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 16.2. UK Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

17. Germany Oncology Molecular Diagnostics Market

  • 17.1. Germany Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 17.2. Germany Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

18. France Oncology Molecular Diagnostics Market

  • 18.4. France Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 18.5. France Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

19. Eastern Europe Oncology Molecular Diagnostics Market

  • 19.1. Eastern Europe Oncology Molecular Diagnostics Market Overview
  • 19.2. Eastern Europe Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 19.3. Eastern Europe Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

20. Russia Oncology Molecular Diagnostics Market

  • 20.1. Russia Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 20.2. Russia Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

21. North America Oncology Molecular Diagnostics Market

  • 21.1. North America Oncology Molecular Diagnostics Market Overview
  • 21.2. North America Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 21.3. North America Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

22. USA Oncology Molecular Diagnostics Market

  • 22.1. USA Oncology Molecular Diagnostics Market Overview
  • 22.2. USA Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 22.3. USA Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

23. South America Oncology Molecular Diagnostics Market

  • 23.1. South America Oncology Molecular Diagnostics Market Overview
  • 23.2. South America Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 23.3. South America Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

24. Brazil Oncology Molecular Diagnostics Market

  • 24.1. Brazil Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 24.2. Brazil Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

25. Middle East Oncology Molecular Diagnostics Market

  • 25.1. Middle East Oncology Molecular Diagnostics Market Overview
  • 25.2. Middle East Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 25.3. Middle East Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

26. Africa Oncology Molecular Diagnostics Market

  • 26.1. Africa Oncology Molecular Diagnostics Market Overview
  • 26.2. Africa Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 26.3. Africa Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

27. Oncology Molecular Diagnostics Market Competitive Landscape And Company Profiles

  • 27.1. Oncology Molecular Diagnostics Market Competitive Landscape
  • 27.2. Oncology Molecular Diagnostics Market Company Profiles
    • 27.2.1. Abbott Diagnostics
      • 27.2.1.1. Overview
      • 27.2.1.2. Products and Services
      • 27.2.1.3. Strategy
      • 27.2.1.4. Financial Performance
    • 27.2.2. Becton Dickinson
      • 27.2.2.1. Overview
      • 27.2.2.2. Products and Services
      • 27.2.2.3. Strategy
      • 27.2.2.4. Financial Performance
    • 27.2.3. Cepheid
      • 27.2.3.1. Overview
      • 27.2.3.2. Products and Services
      • 27.2.3.3. Strategy
      • 27.2.3.4. Financial Performance
    • 27.2.4. Danaher Corporation
      • 27.2.4.1. Overview
      • 27.2.4.2. Products and Services
      • 27.2.4.3. Strategy
      • 27.2.4.4. Financial Performance
    • 27.2.5. Beckman Coulter
      • 27.2.5.1. Overview
      • 27.2.5.2. Products and Services
      • 27.2.5.3. Strategy
      • 27.2.5.4. Financial Performance

28. Key Mergers And Acquisitions In The Oncology Molecular Diagnostics Market

29. Oncology Molecular Diagnostics Market Future Outlook and Potential Analysis

30. Appendix

  • 30.1. Abbreviations
  • 30.2. Currencies
  • 30.3. Research Inquiries
  • 30.4. The Business Research Company
  • 30.5. Copyright And Disclaimer